Nasdaq Announces the Closure of its U.S. Markets in Honor of a National Day of Mourning for President George H.W. Bush
December 01, 2018 12:13 ET
|
Nasdaq, Inc.
NEW YORK, Dec. 01, 2018 (GLOBE NEWSWIRE) -- Nasdaq announces that it will observe the passing of President George H.W. Bush by closing all Nasdaq U.S. equities and options markets on Wednesday,...
Initial Data from Shire Collaboration Identifies Key Biomarkers That Affect Bleeding Patterns, Response to Treatment for Hemophilia A
December 01, 2018 12:00 ET
|
Shire Pharmaceuticals Group
Initial Data from Shire Collaboration Identifies Key Biomarkers That Affect Bleeding Patterns, Response to Treatment for Hemophilia A Data from iPATH Collaboration to be presented at the American...
Bellicum Announces Favorable Interim Event-Free Survival Data for Rivo-cel Treated Patients in Presentation at ASH 2018
December 01, 2018 12:00 ET
|
Bellicum Pharmaceuticals, Inc.
Interim results suggest rivo-cel outcomes were comparable to a control study of transplants from matched unrelated donors, a requirement for product registration in Europe Company on track to report...
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ternium S.A. To Contact The Firm
December 01, 2018 12:00 ET
|
Faruqi & Faruqi LLP
NEW YORK, Dec. 01, 2018 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ternium S.A. (“Ternium” or the “Company”) (NYSE:TX) of the January...
Karyopharm Reports Positive Top-Line Phase 2b SADAL Data for Selinexor in Patients with Diffuse Large B-Cell Lymphoma at the American Society of Hematology 2018 Annual Meeting
December 01, 2018 12:00 ET
|
Karyopharm Therapeutics Inc.
-- 29.6% Overall Response Rate Including 9.6% Complete Response Rate -- -- Amongst the Patients with Complete or Partial Response, Median Duration of Response was 9.2 Months and Median Overall...
Catalyst Biosciences Announces Updated Positive Interim Data from Its Phase 2/3 Study of Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors
December 01, 2018 12:00 ET
|
Catalyst Biosciences, Inc.
Results demonstrate efficacy of subcutaneous prophylaxis with MarzAA, Catalyst’s high potency engineered FVIIa Data presented at 60th American Society of Hematology Annual Meeting & Exposition ...
This is a test from GlobeNewswire
December 01, 2018 11:00 ET
|
GlobeNewswire, Inc.
This is a test from GlobeNewswire. Readers are advised to disregard. TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING -END- CONTACT: Karen YuSenior Director,...
Larson Electronics Releases 480 V, 50 VA Primary Voltage Micro Transformer with 120 V Output Voltage
December 01, 2018 11:00 ET
|
Larson Electronics, LLC
KEMP, Texas, Dec. 01, 2018 (GLOBE NEWSWIRE) -- Larson Electronics, a Texas-based company with over 40 years of experience spearheading the industrial lighting and power equipment sectors, announced...
Novartis announces new crizanlizumab (SEG101) data analysis in sickle cell disease, and investment in SENTRY clinical program
December 01, 2018 10:15 ET
|
Novartis Pharma AG
New post-hoc analysis of SUSTAIN study, presented at ASH 2018, highlights results among patients who were treated per protocol compared with all randomized patientsCrizanlizumab, a monthly...
Oncology Venture: Notice to Convene Extraordinary General Meeting
December 01, 2018 07:14 ET
|
Oncology Venture A/S
INDKALDELSE TIL EKSTRAORDINÆR GENERALFORSAMLINGNOTICE TO CONVENE EXTRAORDINARY GENERAL MEETINGKALLELSE TILL EXTRA BOLAGSSTÄMMA Der indkaldes herved til ekstraordinær generalforsamling i Oncology...
- June 15, 2024 08:57 ET MULTIMEDIA UPDATE -- Rygen Technologies Launches Next-Gen Supply Chain Solution: AI-enabled TMS
- June 14, 2024 21:21 ET Pik'r Range Picking Robot Enhances U.S. Open Experience at Pinehurst